hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304947 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jason Jei-Sheng Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: RNA-Binding Proteins, MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, National Taiwan University Hospital, National Taiwan University.
Abstract (Originalsprache)
The RNA-binding protein LIN28B represses the biogenesis of the tumor suppressor let-7 . The LIN28B/ let-7 axis regulates cell differentiation and is associated with various cancers. The RNA-binding protein Q (hnRNP Q) or SYNCRIP (Synaptotagmin Binding Cytoplasmic RNA Interacting Protein) has been implicated in mRNA splicing, mRNA transport, translation, and miRNAs biogenesis as well as metabolism in cancer. To determine whether hnRNP Q plays a role in the LIN28B/ let-7 axis, we tested for interactions between hnRNP Q and LIN28B. We demonstrated that hnRNP Q interacts with LIN28B in an RNA-dependent manner. Knockdown of hnRNP Q caused reduced expression of a well-known let-7 target TRIM71, an E3 ubiquitin ligase that belongs to the RBCC/TRIM family, and also LIN28B, whose mRNA itself is down-regulated by let-7 . In addition, hnRNP Q knockdown increased let-7 family miRNA levels and reduced the activity of luciferase reporters fused with the TRIM71 3’UTR or a synthetic 3’UTR carrying 8X let-7 complementary sites. Finally, depletion of hnRNP Q inhibited the proliferation of a hepatocellular carcinoma cell line, Huh7. This observation is consistent with the survival curve for liver cancer patients from the TCGA database, which indicates that high expression of hnRNP Q is a prognostic marker for a poor outcome in individuals afflicted with hepatocellular carcinoma. Together, our findings suggest that hnRNP Q interacts with LIN28B and modulates the LIN28B/ let-7 axis in hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
- Genome and Systems Biology Degree Program, College of Life Science, National Taiwan University, Taipei, Taiwan.
ORCID-Profile: Ti Lin, Shih-Peng Chan
Förderung
- Ministry of Science and Technology, Taiwan
- National Taiwan University Hospital
- National Taiwan University
- National Taiwan University Hospital Yunlin Branch
Zitieren
APA
Chang, J. J., Lin, T., Jhang, X. Y., & Chan, S. P. (2024). hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0304947
Vancouver
Chang JJ, Lin T, Jhang XY, Chan SP. hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0304947
BibTeX
@article{Chang2024,
author = {Chang, Jason Jei-Sheng and Lin, Ti and Jhang, Xin-Yue and Chan, Shih-Peng},
title = {hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304947}
}
EUVIMED